United States News
See other United States News Articles
Title: Patent No. 6,630,507: Why the U.S. government holds a patent on cannabis plant compounds
Source:
The Denver Post
URL Source: http://www.denverpost.com/2016/08/2 ... t-is-marijuana-patent-6630507/
Published: Aug 28, 2016
Author: Alicia Wallace
Post Date: 2016-08-28 19:58:04 by Operation 40
Keywords: cannabis, marijuana, patent
Views: 981
Comments: 3
Patent No. 6,630,507: Why the U.S. government holds a patent on cannabis plant compounds The Denver Post By ALICIA WALLACE | awallace@denverpost.com It’s about technology transfer, not legalization It may not have quite the same ring to it as a certain seven-digit phone number made famous by a 1980s pop hit, but 6,630,507 has become internet-famous since the U.S. Drug Enforcement Administration opted not to reschedule marijuana, leaving it in the category of drugs with no legitimate medical uses. Since then, proponents of legalization have responded with a storm of social-media posts highlighting U.S. Patent No. 6,630,507, granted in 2003 to the U.S. Department of Health and Human Services and covering the potential use of non-psychoactive cannabinoids to protect the brain from damage or degeneration caused by certain diseases, such as cirrhosis. They’re telling the DEA to “talk to the hand,” writing “6,630,507” on their palms, hashtagging the number and linking to past articles on the topic. The intent of the posts is symbolic, said Sam Mendez, an intellectual property and public policy lawyer who serves as the executive director of the University of Washington’s Cannabis Law & Policy Project. “Naturally, it shows that there is a certain amount of hypocrisy that there is ‘no accepted medical use’ for cannabis according to federal law,” Mendez said. “And yet here you have the very same government owning a patent for, ostensibly, a medical use for marijuana.” SNIPPED------------------- ...In the case of No. 6,630,507, the researchers discovered that non-psychoactive compounds in cannabis may have antioxidant properties that could be beneficial in the treatment of certain neurological diseases, she said...snip ...Five years ago, the NIH granted New York-based Kannalife Sciences Inc. an exclusive license for the part of the technology outlined in the patent to develop cannabinoid- and cannabidiol-based drugs for the treatment of hepatic encephalopathy — brain damage that could result from conditions such as cirrhosis. Kannalife also has a non-exclusive license to develop drugs to treat chronic traumatic encephalopathy, a rare and progressive degenerative brain condition likely caused by repeated head trauma, Myles said...snip Kannalife: http://kannalife.com READ MORE: http://www.denverpost.com/2016/08/28/what-is-marijuana-patent-6630507/ Poster Comment: The Government lied about Cannabis. How many other lies have they told? Or rather- when have they told the truth about anything in the last 100 years?
Photo courtesy of Willie's Reserve -Willie Nelson holds up a container of his branded marijuana with “6630507” written on it. Following the U.S. Drug Enforcement Administration’s inaction on rescheduling marijuana, legalization proponents have responded by taking to the internet to highlight Patent No. 6,630,507, which covers the potential use of non-psychoactive cannabinoids.
PUBLISHED: August 28, 2016
Post Comment Private Reply Ignore Thread
Top • Page Up • Full Thread • Page Down • Bottom/Latest
Begin Trace Mode for Comment # 3.
#3. To: Operation 40 (#0)
The patent is for the cannabinoid chemical compounds contained in marijuana. Just as the patent is on digitalis, not the deadly foxglove plant it comes from.
There are no replies to Comment # 3. End Trace Mode for Comment # 3.
Top • Page Up • Full Thread • Page Down • Bottom/Latest“Naturally, it shows that there is a certain amount of hypocrisy that there is ‘no accepted medical use’ for cannabis according to federal law,” Mendez said. “And yet here you have the very same government owning a patent for, ostensibly, a medical use for marijuana.”
Replies to Comment # 3.
[Home] [Headlines] [Latest Articles] [Latest Comments] [Post] [Mail] [Sign-in] [Setup] [Help] [Register]